The MFI of GITR from CD45+CD8+ was elevated in both treatment groups; however, statistical significance was observed only in the CaPEF + DCV group when compared to either healthy controls or untreated tumor-bearing mice. The gene discussed is CD8A; the disease is neoplasm.